Background
The human P2Y12 is an ADP receptor involved in platelet aggregation. ADP initiates platelet aggregation by simultaneous activation of two G protein-coupled receptors, P2Y1 and P2Y12. Activation of P2Y1 stimulates phospholipase C and triggers shape change, while P2Y12 coupled to Gi also involved in modulating thrombosis and hemostasis and therefore is a good drug target for antithrombotic drugs. P2Y receptors are expressed in a variety of tissues including platelets, endothelia, smooth muscle, CNS, osteoblasts , β-islet cells as well as in commonly used CHO-K1 and HEK293 cells. We therefore chose to express the P2Y12 receptor in 1321N1 astrocytoma cells, which have minimal endogenous receptor.
| General Info | |
| Synonyms | P2RY12, SP1999, HORK3, P2TAC, or P2T |
|---|---|
| Product Description | Human P2Y12 Purinergic Receptor-expressing GPCR (G protein-coupled receptor) stable, replicating cell line. |
| Target Type | GPCR |
| Product Type | Replicating Cell Line |
| Receptor | Purinergic |
| Sub-Type | P2Y12 |
| Therapeutic Area | pain & inflammation, vascular |
| Related Services | Membrane Preparation, Large-scale Cryopreservation, GPCR Screening |
| Genbank Accession Number | NM_022788 |
| Validated Assay/Platform | calcium |
| References | Nicholas, RA (2001) Identification of the P2Y12 Receptor: A Novel Member of the P2Y Family of Receptors Activated by Extracellular Nucleotides. Mol Pharmacol 60: 416-420. Foster, CJ, et al. (2001) Molecular identification and characterization of th |
| Host cell | 1321N1 astrocytoma expressing Gqi3 |
| Mycoplasma Status | Negative (MycoAlert Kit) |
| Growth media | DMEM, 10% FBS, 0.6 mg/mL G418, 0.5 mg/mL Hygromycin. Split cells at 1:5 |
| Storage & Packaging | |
| Packaging | Cryopreserved cells, 6 million cells per vial |
| Storage Recommendation | liquid nitrogen |
| Stability | Stable up to 12 passages of continuous culture (6 weeks) |
| Quantity | 6 million cells |
| Product Documentation | |
| Specification Sheet | |



